C S Simon - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

C S Simon

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Immunology|March 2, 2023

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.

Cellular Immunology|December 31, 2020

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot studyChristoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.

Oncoimmunology|March 3, 2020

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitorsSonja C S Simon, Xiaoying Hu, Jasper Panten, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Frontiers in Immunology|March 2, 2023

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patientsVera Petrova, Christopher Groth, Rebekka Bitsch, et al.

Cellular Immunology|December 31, 2020

Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot studyChristoffer Gebhardt, Sonja C S Simon, Rebekka Weber, et al.

Oncoimmunology|March 3, 2020

Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitorsSonja C S Simon, Xiaoying Hu, Jasper Panten, et al.

Pageof 2